Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION (Details 1)

v3.23.3
SHARE-BASED COMPENSATION (Details 1) - Stock Options [Member] - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of shares options outstanding, beginning 7,812,178  
Exercise price outstanding, beginning $ 3.70  
Weighted average remaining contractual life (years) 4 years 10 months 9 days [1] 6 years 6 months 21 days
Weighted-average grant date fair value,beginning $ 2.23  
Number of shares options, granted 15,000  
Exercise price granted $ 0.14  
Weighted-average grant date fair value, granted  
Number of shares options, forfeited (352,739)  
Exercise price forfeited $ 2.64  
Weighted-average grant date fair value, forfeited $ 1.52  
Number of shares options expired (139,404)  
Exercise price expired $ 2.81  
Weighted-average grant date fair value, expired $ 1.55  
Number of shares options outstanding, ending 7,335,035 [1] 7,812,178
Exercise price outstanding, ending $ 3.76 [1] $ 3.70
Weighted-average grant date fair value, ending $ 2.00 [1] $ 2.23
Exercisable [2] 5,681,575  
Exercise price outstanding, ending [2] $ 3.91  
Weighted average remaining contractual life (years) exercisable [2] 4 years 10 days  
Weighted-average grant date fair value exercisable [2] $ 2.07  
Intrinsic value of options $ 0  
Intrinsic value of vested/exercisable options $ 0  
[1] There was no aggregate intrinsic value of all stock options outstanding as of September 30, 2023.
[2] There was no aggregate intrinsic value of all vested/exercisable stock options as of September 30, 2023.